Envoy Medical, Inc.
COCHWNasdaq
$0.04
↑ +35.7%Jul 16 close · end-of-day
Price
1Y↓ -29.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2.8M
Enterprise Value
$2.8M
P/E
—
P/S
12.0
P/B
0.3
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$234,000.00
Net Income (TTM)
-$23.1M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
-9881.2%
Net Margin
-9875.6%
ROE
-227.4%
ROIC
-179.8%
Debt / Equity
—
Net Cash
—
Return 1Y
-32.2%
Company profile
Management & directors
- Lucas Brent T.Chief Executive Officer
- Potashnick RobertInterim CFO
Roles derived from SEC Form 4 filings.
Earnings
COCHW Q 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$39,000.00↓ -15.2%
Diluted EPS-$0.08↓ -72.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $237,000.00 | $316,000.00 | $225,000.00 | $241,000.00 |
| Gross profit | — | — | — | — | — |
| Operating income | -$5.2M | -$8.7M | -$18.4M | -$19.3M | -$22.3M |
| Net income | -$251,633.00 | -$15.9M | -$29.9M | -$20.8M | -$23.8M |
| Diluted EPS | — | -$1.57 | -$2.54 | -$1.49 | -$1.23 |
| Operating cash flow | -$3.2M | -$8.8M | -$17.1M | -$17.9M | -$18.2M |
| Free cash flow | — | -$9.0M | -$17.2M | -$18.9M | -$18.4M |
| Gross margin | — | — | — | — | — |
| Operating margin | — | -3673.4% | -5809.8% | -8558.2% | -9240.7% |
| Net margin | — | -6718.6% | -9469.0% | -9242.2% | -9857.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $68,000.00 | $56,000.00 | $42,000.00 | $46,000.00 | $78,000.00 | $42,000.00 | $75,000.00 | $39,000.00 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$4.9M | -$5.0M | -$4.5M | -$5.1M | -$5.1M | -$5.7M | -$6.4M | -$6.0M |
| Net income | -$3.9M | -$6.0M | -$4.6M | -$5.0M | -$5.7M | -$6.5M | -$6.6M | -$4.4M |
| Diluted EPS | -$0.29 | -$0.39 | -$0.40 | -$0.29 | -$0.32 | -$0.35 | -$0.27 | -$0.08 |
| Operating cash flow | -$4.6M | -$2.6M | -$5.1M | -$3.7M | -$4.5M | -$4.3M | -$5.7M | -$6.1M |
| Free cash flow | — | -$3.8M | — | -$3.7M | -$4.5M | -$4.3M | -$5.9M | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -7135.3% | -8878.6% | -10828.6% | -11102.2% | -6500.0% | -13590.5% | -8513.3% | -15279.5% |
| Net margin | -5804.4% | -10642.9% | -10995.2% | -10865.2% | -7294.9% | -15433.3% | -8781.3% | -11156.4% |
Company news
Coming soonHeadlines for COCHW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-29 | Lucas Brent T.· Chief Executive Officer | Award | 32,856 | $0.60 | $19,680.74 | filing |
| 2026-02-12 | TAYLOR GLEN A | Buy | 18,750,000 | $0.40 | $7.5M | filing |
| 2026-02-12 | BRYNELSEN CHARLES | Buy | 1,000,000 | $0.40 | $400,000.00 | filing |
| 2026-02-12 | Patel Mona Chetan | Buy | 312,500 | $0.40 | $125,000.00 | filing |
| 2026-02-12 | Potashnick Robert· Interim CFO | Buy | 212,500 | $0.40 | $85,000.00 | filing |
| 2026-02-12 | Kantor Susan | Buy | 96,150 | $0.40 | $38,460.00 | filing |
| 2026-02-12 | Lucas Brent T.· Chief Executive Officer | Buy | 62,500 | $0.40 | $25,000.00 | filing |
| 2025-11-28 | Lucas Brent T.· Chief Executive Officer | Award | 18,105 | $0.71 | $12,908.87 | filing |
Latest 8 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.